glp-1 agonist weight loss medications alternatives Emerging Drugs and What Pharmacies Need to Know Understanding Weight Loss Medications: GLP-1
Description
Innovent Biologics Inc
MFV, microvascular flow velocity
10.1038/s41598-021-97967-0 Summary Keywords heart failure, GLP-1, glucagon-like peptide-1, clinical trials, cardiovascular disease, cardiovascular outcome studies, diabetes, obesity Citation Kreiner FF, Hovingh GKK and von Scholten BJ (2022) The potential of glucagon-like peptide-1 receptor agonists in heart failure
This family of weight loss drug has taken the obesity and metabolism world by storm, with mixed opinions
Similar effects are elicited by -glucosidase inhibitors, which prevent digestion of starch and oligosaccharides, thus moving the unprocessed nutrients to more distal parts of the gut
Now the situation is changing
